Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 223

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Clinical Phenotype and Mutant TRα1

Open access
van Mullem, Alies, van Heerebeek, Ramona, Chrysis, Dionisios, Visser, Edward, Medici, Marco, Andrikoula, Maria, Tsatsoulis, Agathocles, Peeters, Robin, Visser, Theo J.·2012·New England Journal of Medicine

Abstract

Generic Atorvastatin and Health Care CostsTo the Editor: In their Perspective article on generic atorvastatin and health care costs, Jackevicius et al. (Jan.19 issue) 1 refer to agreements that we at Pfizer have reached with health plans and pharmacy benefit managers to ensure that patients can continue to have access to Lipitor in the 180-day period after the loss of market exclusivity.They ask "whether these agreements will discourage generics manufacturers from competing in the atorvastatin market."We believe our programs (the Lipitor for You program and Lipitor contracting strategies with payers and retail pharmacies) enhance competition by affording both patients and payers access to branded Lipitor at a cost that is at or lower than the cost of a generic during the 180-day period following the loss of market exclusivity.In addition to Lipitor, generic alternatives from Ranbaxy and Watson are also available.After the 180day period, we expect that multiple additional generics will enter the market and that the cost of generic products will decline appreciably.We appreciate the focus on ways to safely and effectively cut costs in the U.S. health care system.We believe we are doing just that by introducing greater competition to the marketplace earlier than would occur without our programs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmc1113940

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 223

Metadata

Authors
van Mullem, A., van Heerebeek, R., Chrysis, D., Visser, E., Medici, M., Andrikoula, M., Tsatsoulis, A., Peeters, R., & Visser, T. J.
Venue
New England Journal of Medicine
Published
2012-04-12
Volume
366
Issue
15
Pages
1451-1453
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W1978781687
Cited by
223
References
1
FWCI
67.42
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Phenotype and Mutant TRα1. https://app.cochat.ai/papers/10.1056/nejmc1113940
The paper
van Mullem, A., van Heerebeek, R., Chrysis, D., Visser, E., Medici, M., Andrikoula, M., Tsatsoulis, A., Peeters, R., & Visser, T. J. (2012). Clinical Phenotype and Mutant TRα1. New England Journal of Medicine. https://doi.org/10.1056/nejmc1113940

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.